Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Edema Secondary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT00375154
What this trial is testing

HERMES STUDY: Study on the Feasibility and Efficiency of Noninvasive Positive-Pressure Ventilation (NPPV) in Prehospital Care

Who this might be right for
ARF Secondary to COPD ExacerbationARF Secondary to Cardiogenic Acute Pulmonary Oedema
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 100
Testing effectiveness (Phase 2)Study completedNCT02614937
What this trial is testing

Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Edema
Ohr Pharmaceutical Inc. 20
Not applicableUnknownNCT04803292
What this trial is testing

Retrospective Cohort Study of Intracerebral Hemorrhage

Who this might be right for
Intracerebral Hemorrhage
Second Affiliated Hospital, Zhejiang University, School of Medicine 10,000
Large-scale testing (Phase 3)Study completedNCT00473330
What this trial is testing

Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)

Who this might be right for
Diabetes MellitusMacular Edema
Genentech, Inc. 377
Not applicableUnknownNCT01581151
What this trial is testing

Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Brian Burke, MPH 30
Early research (Phase 1)Study completedNCT01028248
What this trial is testing

Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion
California Retina Consultants 20
Not applicableStudy completedNCT04595448
What this trial is testing

Lymphatic Function in Patients With Secondary Tricuspid Valve Regurgitation

Who this might be right for
Lymphatic InsufficiencyHeart FailureEdema
University of Aarhus 18
Not applicableStudy completedNCT00562406
What this trial is testing

Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)

Who this might be right for
Macular Edema
Klinikum Ludwigshafen 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06630169
What this trial is testing

Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction

Who this might be right for
Corneal Edema
Aurion Biotech 25
Post-approval studies (Phase 4)UnknownNCT03405376
What this trial is testing

Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion With Macular Edema
Yeungnam University College of Medicine 49
Large-scale testing (Phase 3)Study completedNCT00970957
What this trial is testing

Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 107
Large-scale testing (Phase 3)Study completedNCT00943072
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Macular Edema Secondary to Central Retinal Vein Occlusion
Regeneron Pharmaceuticals 189
Post-approval studies (Phase 4)Study completedNCT01486238
What this trial is testing

Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study

Who this might be right for
Diabetic Macular Edema
Valley Retina Institute 72
Large-scale testing (Phase 3)Study completedNCT05520177
What this trial is testing

A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss

Who this might be right for
Branch Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 351
Post-approval studies (Phase 4)UnknownNCT04062370
What this trial is testing

Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionTreatmentPhotocoagulation Burn to Retina+1 more
Sun Yat-sen University 100
Testing effectiveness (Phase 2)Study completedNCT04667897
What this trial is testing

601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Branch Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Post-approval studies (Phase 4)UnknownNCT03892434
What this trial is testing

Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO

Who this might be right for
Branch Retinal Vein Occlusion With Macular Edema
Yeungnam University College of Medicine 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02411656
What this trial is testing

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

Who this might be right for
EdemaErythemaEstrogen Receptor Negative+6 more
M.D. Anderson Cancer Center 71
Early research (Phase 1)Active Not RecruitingNCT05698329
What this trial is testing

Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaMacular Edema
AiViva BioPharma, Inc. 19
Testing effectiveness (Phase 2)Study completedNCT00407355
What this trial is testing

Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Peter A Campochiaro, MD 40
Next Page